- Home
- GH vs AHR Comparison
GH vs AHR Comparison
Compare GH & AHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GH
- AHR
- Stock Information
- Founded
- GH 2011
- AHR 2013
- Country
- GH United States
- AHR United States
- Employees
- GH N/A
- AHR N/A
- Industry
- GH Medical Specialities
- AHR
- Sector
- GH Health Care
- AHR
- Exchange
- GH Nasdaq
- AHR NYSE
- Market Cap
- GH 4.9B
- AHR 5.2B
- IPO Year
- GH 2018
- AHR 2024
- Fundamental
- Price
- GH $49.14
- AHR $35.88
- Analyst Decision
- GH Strong Buy
- AHR Strong Buy
- Analyst Count
- GH 20
- AHR 7
- Target Price
- GH $54.35
- AHR $37.14
- AVG Volume (30 Days)
- GH 2.2M
- AHR 1.6M
- Earning Date
- GH 08-06-2025
- AHR 08-04-2025
- Dividend Yield
- GH N/A
- AHR 2.79%
- EPS Growth
- GH N/A
- AHR N/A
- EPS
- GH N/A
- AHR N/A
- Revenue
- GH $773,996,000.00
- AHR $2,104,227,000.00
- Revenue This Year
- GH $23.14
- AHR $8.10
- Revenue Next Year
- GH $21.42
- AHR $6.50
- P/E Ratio
- GH N/A
- AHR N/A
- Revenue Growth
- GH 28.20
- AHR 10.53
- 52 Week Low
- GH $20.14
- AHR $14.32
- 52 Week High
- GH $52.92
- AHR $36.33
- Technical
- Relative Strength Index (RSI)
- GH 62.17
- AHR 63.17
- Support Level
- GH $48.00
- AHR $34.86
- Resistance Level
- GH $51.71
- AHR $36.13
- Average True Range (ATR)
- GH 2.67
- AHR 0.86
- MACD
- GH 0.39
- AHR -0.07
- Stochastic Oscillator
- GH 78.60
- AHR 80.43
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
About AHR AMERICAN HEALTHCARE REIT INC
American Healthcare REIT Inc is a healthcare-focused real estate investment trust. It owns a diversified portfolio of clinical healthcare real estate properties, focusing on medical office buildings, skilled nursing facilities, senior housing, hospitals, and other healthcare-related facilities. It has four reportable business segments: integrated senior health campuses, outpatient medical, triple-net leased properties and SHOP. It generates majority of its revenue through Integrated Senior Health Campuses segment.